TGFB1 and interstitial lung disease: Our previous study found that the serum level of TGF-β1, a key factor in the development of diffuse alveolar injury, alveolar endothelial cell necrosis and pulmonary fibrosis [37, 38], was much higher in patients with ILD than in patients without ILD [32].